Atlas Trials

Open-label Safety Extension Study of 15 and 20 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

Clinical trial NCT01323478 · COMPLETED

Trial details

NCT number
NCT01323478
Sponsor
H. Lundbeck A/S
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2011-04-01
Primary completion
2012-09-01
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.